Preferences for Attributes of Sodium Oxybate Treatment: A Discrete Choice Experiment in Patients with Narcolepsy

por Dubow, Jordan, Avidan, Alon Y, Corser, Bruce, Athavale, Amod, Seiden, David, Kushida, Clete
Publicado 2022

Effect of levodopa-carbidopa intestinal gel on resting tremors in patients with advanced Parkinson’s disease

por Fernandez, Hubert H, Robieson, Weining Z, Chatamra, Krai, Dubow, Jordan, Eaton, Susan, Benesh, Janet A, Odin, Per
Publicado 2016

Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial

por Dauvilliers, Yves, Roth, Thomas, Bogan, Richard, Thorpy, Michael J, Morse, Anne Marie, Roy, Asim, Dubow, Jordan, Gudeman, Jennifer
Publicado 2023

Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial

por Roth, Thomas, Dauvilliers, Yves, Thorpy, Michael J., Kushida, Clete, Corser, Bruce C., Bogan, Richard, Rosenberg, Russell, Dubow, Jordan, Seiden, David
Publicado 2022

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer’s Disease

por Waring, Jeffrey F., Tang, Qi, Robieson, Weining Z., King, David P., Das, Ujjwal, Dubow, Jordan, Dutta, Sandeep, Marek, Gerard J., Gault, Laura M.
Publicado 2015

Long-Term PEG-J Tube Safety in Patients With Advanced Parkinson's Disease

por Epstein, Michael, Johnson, David A, Hawes, Robert, Schmulewitz, Nathan, Vanagunas, Arvydas D, Gossen, E Roderich, Robieson, Weining Z, Eaton, Susan, Dubow, Jordan, Chatamra, Krai, Benesh, Janet
Publicado 2016

Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy

por Kushida, Clete A, Shapiro, Colin M, Roth, Thomas, Thorpy, Michael J, Corser, Bruce C, Ajayi, Akinyemi O, Rosenberg, Russell, Roy, Asim, Seiden, David, Dubow, Jordan, Dauvilliers, Yves
Publicado 2021

Efficacy and safety of deflazacort vs prednisone and placebo for Duchenne muscular dystrophy

por Griggs, Robert C., Miller, J. Phillip, Greenberg, Cheryl R., Fehlings, Darcy L., Pestronk, Alan, Mendell, Jerry R., Moxley, Richard T., King, Wendy, Kissel, John T., Cwik, Valerie, Vanasse, Michel, Florence, Julaine M., Pandya, Shree, Dubow, Jordan S., Meyer, James M.
Publicado 2016

Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson'd Disease: Final 12-Month, Open-Label Results

por Fernandez, Hubert H, Standaert, David G, Hauser, Robert A, Lang, Anthony E, Fung, Victor SC, Klostermann, Fabian, Lew, Mark F, Odin, Per, Steiger, Malcolm, Yakupov, Eduard Z, Chouinard, Sylvain, Suchowersky, Oksana, Dubow, Jordan, Hall, Coleen M, Chatamra, Krai, Robieson, Weining Z, Benesh, Janet A, Espay, Alberto J
Publicado 2015

Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials

por Lang, Anthony E., Rodriguez, Ramon L., Boyd, James T., Chouinard, Sylvain, Zadikoff, Cindy, Espay, Alberto J., Slevin, John T., Fernandez, Hubert H., Lew, Mark F., Stein, David A., Odin, Per, Fung, Victor S.C., Klostermann, Fabian, Fasano, Alfonso, Draganov, Peter V., Schmulewitz, Nathan, Robieson, Weining Z., Eaton, Susan, Chatamra, Krai, Benesh, Janet A., Dubow, Jordan
Publicado 2015